IL138246A0 - Certain thiol inhibitors of endothelin-converting enzyme - Google Patents

Certain thiol inhibitors of endothelin-converting enzyme

Info

Publication number
IL138246A0
IL138246A0 IL13824699A IL13824699A IL138246A0 IL 138246 A0 IL138246 A0 IL 138246A0 IL 13824699 A IL13824699 A IL 13824699A IL 13824699 A IL13824699 A IL 13824699A IL 138246 A0 IL138246 A0 IL 138246A0
Authority
IL
Israel
Prior art keywords
endothelin
converting enzyme
certain thiol
thiol inhibitors
inhibitors
Prior art date
Application number
IL13824699A
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of IL138246A0 publication Critical patent/IL138246A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IL13824699A 1998-04-23 1999-04-21 Certain thiol inhibitors of endothelin-converting enzyme IL138246A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6526598A 1998-04-23 1998-04-23
PCT/EP1999/002690 WO1999055726A1 (en) 1998-04-23 1999-04-21 Certain thiol inhibitors of endothelin-converting enzyme

Publications (1)

Publication Number Publication Date
IL138246A0 true IL138246A0 (en) 2001-10-31

Family

ID=22061502

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13824699A IL138246A0 (en) 1998-04-23 1999-04-21 Certain thiol inhibitors of endothelin-converting enzyme

Country Status (16)

Country Link
EP (1) EP1073674A1 (en)
JP (1) JP4350306B2 (en)
KR (1) KR20010034816A (en)
CN (1) CN1297453A (en)
AU (1) AU3819999A (en)
BR (1) BR9909805A (en)
CA (1) CA2323691A1 (en)
HU (1) HUP0101640A3 (en)
ID (1) ID26822A (en)
IL (1) IL138246A0 (en)
NO (1) NO20005293L (en)
PL (1) PL343594A1 (en)
RU (1) RU2000129510A (en)
SK (1) SK15812000A3 (en)
WO (1) WO1999055726A1 (en)
ZA (1) ZA200004680B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6426354B1 (en) 1998-04-23 2002-07-30 Novartis Ag Certain heteroaryl substituted thiol inhibitors of endothelin-converting enzyme
US6423727B1 (en) 1998-04-23 2002-07-23 Novartis Ag Certain thiol inhibitors of endothelin-converting enzyme
WO2001077095A2 (en) * 2000-04-06 2001-10-18 Novartis Ag Derivatives of alpha-mercaptoacetamide
US6777443B2 (en) * 2001-05-15 2004-08-17 Novartis Ag Dipeptide derivatives
US7071169B2 (en) * 2001-09-21 2006-07-04 Novartis Ag Pyrane derivatives as both ACE-and NEP-inhibitors
AR038377A1 (en) 2002-02-08 2005-01-12 Merck & Co Inc DERIVATIVES OF N-BIFENIL-AMINOCICLOALCANCARBOXAMIDA (WITH REPLACEMENT WITH METHYL)
DE60303441T2 (en) 2002-02-08 2006-09-21 Merck & Co., Inc. N-BIPHENYLMETHYLAMINOCYCLOALKANCARBOXAMID-DERIVATIVE
EP2161254B1 (en) 2002-03-05 2014-08-13 Sumitomo Chemical Company, Limited Intermediate for preparing a biaryl compound
CA2510811A1 (en) * 2002-12-20 2004-07-08 Bayer Healthcare Ag Use of substituted 2,5-diamidoindoles for the treatment of urological diseases
US7427611B2 (en) 2003-09-26 2008-09-23 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl)-cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
US7452875B2 (en) 2003-09-26 2008-11-18 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
US7262184B2 (en) 2003-09-26 2007-08-28 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
EP1706121B1 (en) * 2004-01-12 2008-09-03 Solvay Pharmaceuticals B.V. Neutral endopeptidase (nep) and human soluble endopeptidase (hsep) inhibitors for prophylaxis and treatment of neurodegenerative disorders
JP4047365B2 (en) 2006-01-11 2008-02-13 生化学工業株式会社 Cycloalkanecarboxamide derivative and method for producing the same
JP3975226B2 (en) 2006-01-11 2007-09-12 生化学工業株式会社 Cycloalkylcarbonylamino acid derivative and process for producing the same
AU2007205578B2 (en) * 2006-01-11 2012-06-28 Seikagaku Corporation Cycloalkylcarbonylamino acid ester derivative and process for producing the same
WO2009105140A2 (en) 2007-12-11 2009-08-27 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
CN104725279B (en) * 2015-02-12 2018-03-02 威海迪素制药有限公司 A kind of preparation method of N Boc biphenylalanine derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9407933A (en) * 1993-11-01 1996-11-26 Japat Ltd Endothelin receptor antagonists
ATE193706T1 (en) * 1993-11-16 2000-06-15 Novartis Ag CYCLIC AMINO ACID DERIVATIVES WITH ACE AND NEP INHIBITING ACTIVITY
FR2745571B1 (en) * 1996-03-04 1998-06-19 Inst Nat Sante Rech Med NOVEL SULFUR DERIVATIVES COMPRISING AN AMIDE BINDING, THEIR PREPARATION PROCESS, THEIR USE AS MEDICAMENTS, AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
CA2323691A1 (en) 1999-11-04
WO1999055726A1 (en) 1999-11-04
CN1297453A (en) 2001-05-30
PL343594A1 (en) 2001-08-27
AU3819999A (en) 1999-11-16
BR9909805A (en) 2000-12-26
JP4350306B2 (en) 2009-10-21
JP2002513032A (en) 2002-05-08
SK15812000A3 (en) 2001-03-12
HUP0101640A3 (en) 2002-10-28
ID26822A (en) 2001-02-15
ZA200004680B (en) 2001-04-25
NO20005293D0 (en) 2000-10-20
RU2000129510A (en) 2002-11-10
HUP0101640A2 (en) 2001-09-28
NO20005293L (en) 2000-12-18
EP1073674A1 (en) 2001-02-07
KR20010034816A (en) 2001-04-25

Similar Documents

Publication Publication Date Title
PL343007A1 (en) Inhibitors of phospholipase enzymes
IL137718A0 (en) Inhibitors of phospholipase enzymes
IL138387A0 (en) Enzyme inhibitors
IL128080A0 (en) Thiol sulfonamide metalloprotease inhibitors
EP1127054A4 (en) Novel inhibitors of impdh enzyme
IL138246A0 (en) Certain thiol inhibitors of endothelin-converting enzyme
AU3665199A (en) Inhibitors of impdh enzyme
CY2528B1 (en) Inhibitors of cysteine protease
PL349192A1 (en) Protease inhibitors
IL133368A0 (en) Urokinase inhibitors
PL334846A1 (en) Sulphamidic inhibitors of metaloproteases
EP0923535A4 (en) Inhibitors of cysteine protease
EP1093367A4 (en) Protease inhibitors
AU3124300A (en) Inhibitors of beta-lactamases and uses therefor
PL337725A1 (en) Inhibitors of proteases
AU9059798A (en) Urokinase inhibitors
AU2190400A (en) Inhibitors of beta-lactamases and uses therefor
EP1067894A4 (en) Protease inhibitors
ZA983065B (en) Inhibitors of protein farnesyltranferase
HK1039276A1 (en) Hydroxamate-containing cysteine and serine protease inhibitors
EP1079821A4 (en) Protease inhibitors
AU1393900A (en) Morpholino-ethoxybenzofuran protease inhibitors
GB9924522D0 (en) Enzyme inhibitors
GB9806287D0 (en) Monobactam enzyme inhibitors
EP1140897A4 (en) Protease inhibitors